Back to Journals » OncoTargets and Therapy » Understand and target the complexity of the tumor milieu
OncoTargets and Therapy
- View all (6756)
- Volume 19, 2026 (71)
- Volume 18, 2025 (105)
- Volume 17, 2024 (142)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Journal Articles:
- Radiation Therapies for Cancer (1)
- Advances in Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatment (5)
- Cancer Immunotherapy: Harnessing the Immune System for Cancer Treatments (3)
Understand and target the complexity of the tumor milieu
The process of tumor initiation and progression is influenced by genetic/epigenetic alterations in tumor cells and the rearrangement of the tumor microenvironment (TME) through complex signaling networks. The TME consists of various components, including tumor cells, stromal fibroblasts, endothelial cells, immune cells, and extracellular matrix (ECM) components. Crosstalk between tumor cells and these non-malignant cells in the TME plays a critical role in promoting tumorigenesis, metastasis, and drug resistance. This Article Collection focuses on the molecular interactions between cancer cells and TME components, the link between tumor heterogeneity and metabolic plasticity, and related strategies that can bridge the gap between preclinical and clinical research.
